{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:32:22Z","timestamp":1790317942438,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s11910-023-01277-z","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T05:01:32Z","timestamp":1685336492000},"page":"381-387","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hemiplegic Migraine"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7907-8676","authenticated-orcid":false,"given":"Arathi","family":"Nandyala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulsi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ailani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,29]]},"reference":[{"issue":"1","key":"1277_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-2982.2008.01709.x","volume":"38","author":"J Olesen","year":"2018","unstructured":"Olesen J. Headache classification committee of the international headache society (IHS) the international classification of headache disorders. Cephalalgia. 2018;38(1):1\u2013211.","journal-title":"Cephalalgia."},{"issue":"5","key":"1277_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1046\/j.1468-2982.2002.00371.x","volume":"22","author":"LL Thomsen","year":"2002","unstructured":"Thomsen LL, Eriksen MK, Romer SF, Andersen I, Ostergaard E, Keiding N, Olesen J, Russell MB. An epidemiological survey of hemiplegic migraine. Cephalalgia. 2002;22(5):361\u201375.","journal-title":"Cephalalgia."},{"issue":"11-12","key":"1277_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/milmed\/usz040","volume":"184","author":"BA Moore","year":"2019","unstructured":"Moore BA, Hale WJ, Nabity PS, Koehn TR, McGeary D, Peterson AL. A retrospective, epidemiological review of hemiplegic migraines in a military population. Mil Med. 2019;184(11-12):781\u20137.","journal-title":"Mil Med."},{"issue":"7","key":"1277_CR4","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/jnnp-2020-322850","volume":"91","author":"V Di Stefano","year":"2020","unstructured":"\u2022 Di Stefano V, Rispoli MG, Pellegrino N, Graziosi A, Rotondo E, Napoli C, Pietrobon D, Brighina F, Parisi P. Diagnostic and therapeutic aspects of hemiplegic migraine. J Neurol Neurosurg Psychiatry. 2020;91(7):764\u201371. Detailed review of differential diagnosis and studied treatment options.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"4","key":"1277_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1212\/01.WNL.0000046524.25369.7D","volume":"60","author":"LL Thomsen","year":"2003","unstructured":"Thomsen LL, Ostergaard E, Olesen J, Russell MB. Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology. 2003;60(4):595\u2013601.","journal-title":"Neurology."},{"key":"1277_CR6","doi-asserted-by":"crossref","unstructured":"Vincent M, Hadjikhani N. The cerebellum and migraine. Headache. 2007;47(6):820\u201333.","DOI":"10.1111\/j.1526-4610.2006.00715.x"},{"issue":"6","key":"1277_CR7","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/head.13505","volume":"59","author":"EM Trahan","year":"2019","unstructured":"Trahan EM, Mercado JM. Familial hemiplegic migraines and baseline neuropsychological testing: a case report. Headache. 2019;59(6):917\u201323.","journal-title":"Headache."},{"issue":"3","key":"1277_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/head.13741","volume":"60","author":"AS Sprouse Blum","year":"2020","unstructured":"Sprouse Blum AS, Couperus CJ, Rosen BJ, Haskin-Leahy LF, Shapiro RE. Familial \u201cdiplegic\u201d migraine\u2013description of a family with a novel CACNA1A mutation. Headache. 2020;60(3):600\u20136.","journal-title":"Headache."},{"issue":"1","key":"1277_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-021-01221-x","volume":"22","author":"F Antonaci","year":"2021","unstructured":"Antonaci F, Ravaglia S, Grieco GS, Gagliardi S, Cereda C, Costa A. Familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A2. J Headache Pain. 2021;22(1):1\u20136.","journal-title":"J Headache Pain."},{"issue":"11","key":"1277_CR10","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1177\/0333102419847738","volume":"39","author":"W Tang","year":"2019","unstructured":"Tang W, Zhang M, Qiu E, Kong S, Li Y, Liu H, Dong Z, Yu S. A Chinese family with familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A2. Cephalalgia. 2019;39(11):1382\u201395.","journal-title":"Cephalalgia."},{"issue":"2","key":"1277_CR11","doi-asserted-by":"crossref","first-page":"251581631988163","DOI":"10.1177\/2515816319881630","volume":"11","author":"N Maksemous","year":"2019","unstructured":"Maksemous N, Smith RA, Sutherland HG, Maher BH, Ibrahim O, Nicholson GA, Carpenter EP, Lea RA, Cader MZ, Griffiths LR. Targeted next generation sequencing identifies a genetic spectrum of DNA variants in patients with hemiplegic migraine. Cephalalgia Rep. 2019;11(2):2515816319881630.","journal-title":"Cephalalgia Rep."},{"issue":"4","key":"1277_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/0333102418788336","volume":"39","author":"S Bertelli","year":"2019","unstructured":"Bertelli S, Barbieri R, Pusch M, Gavazzo P. Gain of function of sporadic\/familial hemiplegic migraine-causing SCN1A mutations: use of an optimized cDNA. Cephalalgia. 2019;39(4):477\u201388.","journal-title":"Cephalalgia."},{"issue":"1","key":"1277_CR13","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1212\/WNL.0000000000012947","volume":"98","author":"Riant F, Roos C, Roubertie A, Barba","year":"2022","unstructured":"\u2022\u2022 Riant F, Roos C, Roubertie A, Barbance C, Hadjadj J, Auvin S, Baille G, Beltramone M, Boulanger C, Cahn A, Cata F. Hemiplegic migraine associated with PRRT2 variations: a clinical and genetic study. Neurology. 2022;98(1):e51\u201361. Study related to newly identified gene variant, PRRT2.","journal-title":"Neurology."},{"key":"1277_CR14","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Paucar M, Granberg T, Lagerstedt-Robinson K, Waldenlind E, Petersson S, Nordin L, Svenningsson P. SLC1A3 variant associated with hemiplegic migraine and acetazolamide-responsive MRS changes. Neurology. Genetics. 2020;6(4).\u00a0https:\/\/doi.org\/10.1212\/NXG.0000000000000474Case report describing new SCL1A3 variant.","DOI":"10.1212\/NXG.0000000000000474"},{"key":"1277_CR15","unstructured":"Kumar A, Samanta D, Emmady PD, Arora R. Hemiplegic migraine. 2018."},{"issue":"12","key":"1277_CR16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/j.1468-2982.2004.00788.x","volume":"24","author":"LL Thomsen","year":"2004","unstructured":"Thomsen LL, Olesen J. Sporadic hemiplegic migraine. Cephalalgia. 2004;24(12):1016\u201323.","journal-title":"Cephalalgia."},{"issue":"14","key":"1277_CR17","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1177\/0333102419861710","volume":"39","author":"G Magni","year":"2019","unstructured":"Magni G, Boccazzi M, Bodini A, Abbracchio MP, van den Maagdenberg AM, Ceruti S. Basal astrocyte and microglia activation in the central nervous system of familial hemiplegic migraine type I mice. Cephalalgia. 2019;39(14):1809\u201317.","journal-title":"Cephalalgia."},{"issue":"4","key":"1277_CR18","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1212\/01.WNL.0000151855.98318.50","volume":"64","author":"M Dichgans","year":"2005","unstructured":"Dichgans M, Herzog J, Freilinger T, Wilke M, Auer DP. 1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1. Neurology. 2005;64(4):608\u201313.","journal-title":"Neurology."},{"issue":"6","key":"1277_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1177\/0333102410392068","volume":"31","author":"I Toldo","year":"2011","unstructured":"Toldo I, Cecchin D, Sartori S, Calderone M, Mardari R, Cattelan F, Laverda AM, Drigo P, Battistella PA. Multimodal neuroimaging in a child with sporadic hemiplegic migraine: a contribution to understanding pathogenesis. Cephalalgia. 2011;31(6):751\u20136.","journal-title":"Cephalalgia."},{"issue":"2","key":"1277_CR20","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/head.13687","volume":"60","author":"R Wang","year":"2020","unstructured":"Wang R, Nie X, Xu S, Zhang M, Dong Z, Yu S. Interrelated pathogenesis? Neuronal intranuclear inclusion disease combining with hemiplegic migraine. Headache. 2020;60(2):382\u201395.","journal-title":"Headache."},{"key":"1277_CR21","doi-asserted-by":"publisher","unstructured":"Gastaut JL, Yermenos E, Bonnefoy M, Cros D. Familial hemiplegic migraine: EEG and CT scan study of two cases. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 1981;10(4):392\u2013395. https:\/\/doi.org\/10.1002\/ana.410100414","DOI":"10.1002\/ana.410100414"},{"issue":"5","key":"1277_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1474-4422(11)70048-5","volume":"10","author":"MB Russell","year":"2011","unstructured":"Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol. 2011;10(5):457\u201370.","journal-title":"Lancet Neurol."},{"issue":"2","key":"1277_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/0333102418794481","volume":"39","author":"A Pellerin","year":"2019","unstructured":"Pellerin A, Marois C, Mezouar N, Mokhtari K, Leclercq D, Law-Ye B. Neuronal injuries evidenced by transient cortical magnetic resonance enhancement in hemiplegic migraine: a case report. Cephalalgia. 2019;39(2):323\u20135.","journal-title":"Cephalalgia."},{"key":"1277_CR24","unstructured":"Jen JC . Familial Hemiplegic Migraine. GeneReviews\u00ae [Internet] 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1388\/"},{"issue":"9","key":"1277_CR25","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1468-1331.2007.01900.x","volume":"14","author":"V Artto","year":"2007","unstructured":"Artto V, Nissil\u00e4 M, Wessman M, Palotie A, F\u00e4rkkil\u00e4 M, Kallela M. Treatment of hemiplegic migraine with triptans. Eur J Neurol. 2007;14(9):1053\u20136.","journal-title":"Eur J Neurol."},{"issue":"5","key":"1277_CR26","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/head.12804","volume":"56","author":"PG Mathew","year":"2016","unstructured":"Mathew PG, Krel R, Buddhdev B, Ansari H, Joshi SG, Spinner WD, Klein BC. A retrospective analysis of triptan and dhe use for basilar and hemiplegic migraine. Headache. 2016;56(5):841\u20138.","journal-title":"Headache."},{"issue":"8","key":"1277_CR27","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/head.13601","volume":"59","author":"PG Mathew","year":"2019","unstructured":"Mathew PG, Klein BC. Getting to the heart of the matter: migraine, triptans, DHE, ditans, CGRP antibodies, first\/second-generation gepants, and cardiovascular risk. Headache. 2019;59(8):1421\u20136.","journal-title":"Headache."},{"issue":"7","key":"1277_CR28","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/head.13317","volume":"58","author":"TY Chen","year":"2018","unstructured":"Chen TY, Garza I, Dodick DW, Robertson CE. The effect of OnabotulinumtoxinA on aura frequency and severity in patients with hemiplegic migraine: case series of 11 patients. Headache. 2018;58(7):973\u201385.","journal-title":"Headache."},{"issue":"112","key":"1277_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pediatrneurol.2020.07.009","volume":"1","author":"F Dannenberg","year":"2020","unstructured":"Dannenberg F, Prager C, Schmidt F, Tietze A, Bittigau P, Kaindl AM. Intravenous nimodipine treatment for severe episode of ATP1A2 hemiplegic migraine. Pediatr Neurol. 2020;1(112):71\u20132.","journal-title":"Pediatr Neurol."},{"issue":"4","key":"1277_CR30","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1526-4610.2011.01861.x","volume":"51","author":"JM Hansen","year":"2011","unstructured":"Hansen JM, Thomsen LL, Olesen J, Ashina M. Calcitonin gene-related peptide does not cause migraine attacks in patients with familial hemiplegic migraine. Headache. 2011;51(4):544\u201353.","journal-title":"Headache."},{"issue":"11","key":"1277_CR31","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1212\/01.wnl.0000325482.64106.3f","volume":"71","author":"JM Hansen","year":"2008","unstructured":"Hansen JM, Thomsen LL, Olesen J, Ashina M. Calcitonin gene\u2013related peptide does not cause the familial hemiplegic migraine phenotype. Neurology. 2008;71(11):841\u20137.","journal-title":"Neurology."},{"issue":"1","key":"1277_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1212\/WNL.55.1.139","volume":"55","author":"H Kaube","year":"2000","unstructured":"Kaube H, Herzog J, K\u00e4ufer T, Dichgans M, Diener HC. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology. 2000;55(1):139\u201341.","journal-title":"Neurology."}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-023-01277-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-023-01277-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-023-01277-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T12:16:07Z","timestamp":1687436167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-023-01277-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,29]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1277"],"URL":"https:\/\/doi.org\/10.1007\/s11910-023-01277-z","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,29]]},"assertion":[{"value":"16 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Arathi Nandyala: none.Tulsi Shah: none.Jessica Ailani:-Stock\/stock options: CtrlM (2022)-Editorial Boards\/Steering Committee: Medscape, NeurologyLive, Current Pain and Headache (Editor, Unusual Headache Syndromes), SELF magazine (medical editor)-Leadership or fiduciary role in other board society, committee or advocacy group: American Headache Society (unpaid)-Participation on a Data Safety Monitoring Board or Advisory Board: Aeon (migraine) and Gore (migraine)-Consulting fees: Abbvie, Amgen, Axsome, Biohaven, BioDeliveryScientificInternational (2022), Eli-Lilly, GlaxoSmithKline, Lundbeck, Linpharma, Impel, Miravio, Pfizer, Neurolief, Neso, Satsuma, Theranica, Teva-Grants or contracts from any entity: Clinical Trials (Grant to institution)\u2014Abbvie (2021), Biohaven (2021), Eli-Lilly (2021), Satsuma (2022), Zosano (2021)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}